Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T45516
(Former ID: TTDI01178)
|
|||||
Target Name |
Cyclin D1 synthesis (CCND1 synthesis)
|
|||||
Synonyms |
Cyclin D1 biosynthesis
Click to Show/Hide
|
|||||
Gene Name |
NO-GeName
|
|||||
Target Type |
Clinical trial target
|
[1] | ||||
Disease | [+] 1 Target-related Diseases | + | ||||
1 | Neutropenia [ICD-11: 4B00] | |||||
UniProt ID |
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Clinical Trial Drug(s) | [+] 1 Clinical Trial Drugs | + | ||||
1 | GORALATIDE | Drug Info | Phase 2 | Constitutional neutropenia | [2] | |
Mode of Action | [+] 1 Modes of Action | + | ||||
Modulator | [+] 1 Modulator drugs | + | ||||
1 | GORALATIDE | Drug Info | [1] |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | Reduction of heat-induced haemotoxicity in a hyperthermic purging protocol of murine acute myeloid leukaemic stem cells by AcSDKP. Br J Haematol. 1997 Dec;99(3):692-8. | |||||
REF 2 | Thymosin beta4 and its degradation product, Ac-SDKP, are novel reparative factors in renal fibrosis. Kidney Int. 2013 December; 84(6): 10.1038/ki.2013.209. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.